The Association Between Glycemic Variability and Myocardial Infarction: A Review and Meta-Analysis of Prospective Studies and Randomized Trials
- PMID: 33364084
- PMCID: PMC7749861
- DOI: 10.7759/cureus.11556
The Association Between Glycemic Variability and Myocardial Infarction: A Review and Meta-Analysis of Prospective Studies and Randomized Trials
Abstract
Diabetes mellitus is a major risk factor for vascular complications and mortality, glycemic variability (GV) has emerged as a measure of time and magnitude of plasma glucose, its association with cardiovascular complications is controversial. The current study aimed to assess the association of GV with myocardial infarction. An electronic literature search was conducted in PubMed, Medline, and Google Scholar databases for relevant articles. Articles in the English language during the period from 2010 to April 2020 were eligible. The keywords fasting blood glucose variability (FBGV), glucose variability, myocardial infarction, and acute coronary syndrome, were used with the protean OR and AND. Out of the 185 articles retrieved, only seven full texts fulfilled the inclusion and exclusion criteria. The author's name, year of publication, the study type, number of patients, and the results were extracted. There were seven full texts, one from Brazil, one from Australia, two from the USA, and three from Asia. Two were randomized controlled trials and five were prospective cohorts (included 109,058 participants). A significant negative association was found between GV and myocardial infarction, odd ratio (OD) 1.93, 95% CI=1.08-3.44, P-value=0.03, I2 for heterogeneity=87%, P-value=0.0001. However, it is difficult to reach a conclusion due to the small number of the included studies and the high heterogeneity observed. Further well-controlled trials using the same methods are needed to resolve the issue.
Keywords: glucose variability; hba1c variability; myocardial infarction.
Copyright © 2020, Alatawi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Glucose variability: a review of clinical applications and research developments. Rodbard D. Diabetes Technol Ther. 2018;20:25–215. - PubMed
-
- Glucose variability, HbA1c and microvascular complications. Škrha J, Šoupal J, Škrha J Jr, Prázný M. Rev Endocr Metab Disord. 2016;17:103–110. - PubMed
-
- Impact of visit-to-visit fasting plasma glucose variability on the development of type 2 diabetes: a nationwide population-based cohort study. Kim JA, Lee JS, Chung HS, et al. Diabetes Care. 2018;41:2610–2616. - PubMed
-
- Glucose variability and coronary artery disease. Xia J, Yin C. Heart Lung Circ. 2019;28:553–559. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous